Achieve life sciences, inc. announces closing of $17.3 million underwritten public offering, including full exercise of overallotment option

Seattle and vancouver, b.c., dec. 7, 2020 /prnewswire/ -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the...
ACHV Ratings Summary
ACHV Quant Ranking